What does it look like to run a modern cath lab outside the U.S.? Jason Money, RN, RCIS, shares a unique perspective shaped by more than two decades working in New Zealand’s public healthcare system.
What does it look like to run a modern cath lab outside the U.S.? Jason Money, RN, RCIS, shares a unique perspective shaped by more than two decades working in New Zealand’s public healthcare system.
Brian C. Case, MD; Bailey Ann Richardson, MSN, AGNP, RN-BC, RNFA, CNOR, RCIS
Bailey Richardson, MSN, speaks with Brian Case, MD, about coronary microvascular dysfunction and why “normal” angiography can miss the cause of symptoms in patients with angina with non-obstructive coronary arteries (ANOCA).
Bailey Richardson, MSN, speaks with Brian Case, MD, about coronary microvascular dysfunction and why “normal” angiography can miss the cause of symptoms in patients with angina with non-obstructive coronary arteries (ANOCA).
In this 29-minute video (chapters available), Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring with the CardioMEMS™ HF System made by Abbott shifts management from reactive to proactive by detecting hemodynamic...
In this 29-minute video (chapters available), Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring with the CardioMEMS™ HF System made by Abbott shifts management from reactive to proactive by detecting hemodynamic...
In this 29-minute podcast, Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring shifts management from reactive to proactive by detecting hemodynamic congestion before clinical deterioration occurs.
In this 29-minute podcast, Matthew H. Gonzalez, MD, discusses how pulmonary artery pressure monitoring shifts management from reactive to proactive by detecting hemodynamic congestion before clinical deterioration occurs.
In this 35-minute podcast, Dr. Kaple discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
In this 35-minute podcast, Dr. Kaple discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
Market tends are showing that more procedures are moving to out-of-hospital care settings, such as ambulatory surgery centers (ASCs) and office-based labs (OBLs) due to financial and operational benefits to the healthcare system and desire to...
Market tends are showing that more procedures are moving to out-of-hospital care settings, such as ambulatory surgery centers (ASCs) and office-based labs (OBLs) due to financial and operational benefits to the healthcare system and desire to...
In this video, Ryan K. Kaple, MD, FACC, FSCAI, discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
In this video, Ryan K. Kaple, MD, FACC, FSCAI, discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
Bailey Ann Richardson, MSN, AGNP, RN-BC, RNFA, CNOR, RCIS; Morton J. Kern, MD, MSCAI, FACC, FAHA; Arnold H. Seto, MD, MPA, CCDS, FACC, FSCAI
A discussion of the study presented at SCAI's 2025 Annual Meeting, " Percutaneous Coronary Intervention in Ambulatory Surgery Centers: Procedural Volume Trends and Outcomes in the Medicare Population".
A discussion of the study presented at SCAI's 2025 Annual Meeting, " Percutaneous Coronary Intervention in Ambulatory Surgery Centers: Procedural Volume Trends and Outcomes in the Medicare Population".
“In appropriately selected patients who survived a heart attack and do not have heart failure or left ventricular systolic dysfunction, routine continuation of beta-blockers indefinitely may not be necessary,” said Joo-Yong Hahn, MD.
“In appropriately selected patients who survived a heart attack and do not have heart failure or left ventricular systolic dysfunction, routine continuation of beta-blockers indefinitely may not be necessary,” said Joo-Yong Hahn, MD.
The study followed nearly 12,000 adults for approximately 16 years. Investigators applied AI to participants' standard coronary artery calcium scans to measure fat surrounding the heart.
The study followed nearly 12,000 adults for approximately 16 years. Investigators applied AI to participants' standard coronary artery calcium scans to measure fat surrounding the heart.
In July, Leapfrog will publicly report patient safety and quality data on thousands more ASCs on its website, allowing patients, purchasers and employers to search by procedure and compare ASCs side-by-side on evidence-based safety and...
In July, Leapfrog will publicly report patient safety and quality data on thousands more ASCs on its website, allowing patients, purchasers and employers to search by procedure and compare ASCs side-by-side on evidence-based safety and...
Treatment with enlicitide resulted in statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol (LDL-C) compared to bempedoic acid, ezetimibe or bempedoic acid with ezetimibe at eight weeks (day 56)...
Treatment with enlicitide resulted in statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol (LDL-C) compared to bempedoic acid, ezetimibe or bempedoic acid with ezetimibe at eight weeks (day 56)...
The study utilized Tempus Next, an AI platform that identifies significant AS or MR patients who may meet guideline-indicated therapy criteria, but do not have a treatment plan in place.
The study utilized Tempus Next, an AI platform that identifies significant AS or MR patients who may meet guideline-indicated therapy criteria, but do not have a treatment plan in place.
The new TRISCEND II trial data presented during a late-breaking featured research session at ACC.26 demonstrated confidence in two-year performance of TTVR with the EVOQUE system.
The new TRISCEND II trial data presented during a late-breaking featured research session at ACC.26 demonstrated confidence in two-year performance of TTVR with the EVOQUE system.
In a statement, Drs. Martin Leon, Ajay Kirtane, William Fearon, and Allen Jeremias stated: "The compelling results should serve as the impetus to increase adoption of physiology worldwide."
In a statement, Drs. Martin Leon, Ajay Kirtane, William Fearon, and Allen Jeremias stated: "The compelling results should serve as the impetus to increase adoption of physiology worldwide."
At the American College of Cardiology (ACC) 2026 Scientific Session, Boston Scientific presented results from two late-breaking randomized controlled trials evaluating device-based approaches in cardiovascular care: CHAMPION-AF, studying the...
At the American College of Cardiology (ACC) 2026 Scientific Session, Boston Scientific presented results from two late-breaking randomized controlled trials evaluating device-based approaches in cardiovascular care: CHAMPION-AF, studying the...
MOMENTUM is described as the first U.S.-based study and the largest study to date to assess the prevalence of hypercortisolism among individuals with resistant hypertension. Researchers analyzed 1,086 participants across 50 centers in the...
MOMENTUM is described as the first U.S.-based study and the largest study to date to assess the prevalence of hypercortisolism among individuals with resistant hypertension. Researchers analyzed 1,086 participants across 50 centers in the...